Cancer Family
Malignant Digestive System Neoplasm
CI-CAN-00000229Explore in graph →
4,262 active trials43 approved drugs556 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000229Explore in graph →
Clinical trials
19,101 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (2,000)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00562666 | Immunotherapy of Hepatocellular Carcinoma With Gamma Delta T Cells(ICAR) | terminated | Phase 1 | 2 | Rennes University HospitalOTHER | 1 | Jun 22, 2012 | clinicaltrials |
| NCT00057980 | Epirubicin and Celecoxib in Treating Patients With Hepatocellular Carcinoma | completed | Phase 1 / Phase 2 | 8 | Northwestern UniversityOTHER | 1 | Jun 11, 2012 | clinicaltrials |
| NCT00445861 | Cetuximab, Docetaxel, Cisplatin, and Radiation Therapy in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed by Surgery | completed | Phase 1 / Phase 2 | 27 | Swiss Cancer InstituteOTHER | 1 | Jun 11, 2012 | clinicaltrials |
| NCT00004910 | Endoscopic Placement of Metal Stents in Treating Patients With Cancer- Related Duodenal Obstruction | completed | Phase 1 / Phase 2 | — | Northwestern UniversityOTHER | 1 | Jun 6, 2012 | clinicaltrials |
| NCT00004911 | Endoscopic Placement of Metal Stent in Patients With Cancer-Related Bowel Obstruction | completed | Phase 1 / Phase 2 | — | Northwestern UniversityOTHER | 1 | Jun 6, 2012 | clinicaltrials |
| NCT00556023 | A Phase 1 Study Testing CP-675,206 In Combination With Gemcitabine In Patients With Previously Untreated, Advanced Pancreatic Cancer | completed | Phase 1 | 37 | AstraZenecaINDUSTRY | 2 | Jun 6, 2012 | clinicaltrials |
| NCT00217711 | Oxaliplatin, Irinotecan, and Capecitabine in Treating Patients With Advanced or Metastatic Colorectal Cancer That Cannot Be Removed By Surgery | completed | Phase 1 / Phase 2 | 23 | Swiss Cancer InstituteOTHER | 1 | Jun 5, 2012 | clinicaltrials |
| NCT00004904 | Stem Cell Transplantation in Treating Patients With Hematologic Cancer | completed | Phase 1 | — | Northwestern UniversityOTHER | 1 | Jun 4, 2012 | clinicaltrials |
| NCT00002984 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced or Metastatic Cancer of the Esophagus | completed | Phase 1 / Phase 2 | 26 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | May 24, 2012 | clinicaltrials |
| NCT00767468 | Sorafenib in Treating Patients With Locally Advanced or Metastatic Liver Cancer and Cirrhosis | terminated | Phase 1 | 6 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | May 23, 2012 | clinicaltrials |
| NCT00467116 | PhI Study of Erbitux & Gemcitabine w/Radiation Therapy for Locally Adv. Pancreas Ca | completed | Phase 1 | 9 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | May 18, 2012 | clinicaltrials |
| NCT01051284 | A Study of Gemcitabine and Cyberknife Radiation Therapy for Pancreatic Cancer | completed | Phase 1 | 14 | Georgetown UniversityOTHER | 1 | Apr 24, 2012 | clinicaltrials |
| NCT00753844 | Human Leukocyte Antigen (HLA) - A*2402 Restricted Peptide Vaccine Therapy in Patients With Advanced Esophageal Cancer | completed | Phase 1 | 7 | Kinki UniversityOTHER | 1 | Apr 6, 2012 | clinicaltrials |
| NCT00845611 | Human Leukocyte Antigen (HLA) - A*2402 Restricted Peptide Vaccine Therapy in Patients With Advanced Gastric Cancer | completed | Phase 1 | 9 | Kinki UniversityOTHER | 1 | Apr 6, 2012 | clinicaltrials |
| NCT00626158 | Gemcitabine and Capecitabine to Treat Patients With Advanced Pancreatic and Biliary Cancers | completed | Phase 1 | 45 | University of California, San FranciscoOTHER | 1 | Apr 4, 2012 | clinicaltrials |
| NCT00662246 | Dose Escalation Study Using Proton Beam Radiotherapy for Hepatocellular Carcinoma | completed | Phase 1 | 24 | National Cancer Center, KoreaOTHER_GOV | 1 | Apr 3, 2012 | clinicaltrials |
| NCT00784290 | Phase I/II Study of TSU-68 for Advanced Hepatocellular Carcinoma | completed | Phase 1 / Phase 2 | 35 | Taiho Pharmaceutical Co., Ltd.INDUSTRY | 1 | Mar 26, 2012 | clinicaltrials |
| NCT00019513 | Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or Lymphomas | completed | Phase 1 | 108 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 23, 2012 | clinicaltrials |
| NCT00503932 | Proton Therapy With Capecitabine for Rectal Cancer | withdrawn | Phase 1 / Phase 2 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Mar 22, 2012 | clinicaltrials |
| NCT00873002 | Panobinostat and Sorafenib in Treating Patients With Liver Cancer That is Metastatic and/or Cannot Be Removed by Surgery | terminated | Phase 1 | 3 | Case Comprehensive Cancer CenterOTHER | 1 | Mar 20, 2012 | clinicaltrials |
| NCT01126450 | Lenalidomide and Cetuximab in Treating Patients With Metastatic Colorectal Cancer | terminated | Phase 1 | 3 | Case Comprehensive Cancer CenterOTHER | 1 | Mar 20, 2012 | clinicaltrials |
| NCT00547612 | Positron Emission Tomography Using [18F]-Labeled Substance P Antagonist Receptor Quantifier in Finding Disease in Patients With Pancreatic Cancer | completed | Phase 1 | 33 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 16, 2012 | clinicaltrials |
| NCT00734890 | Vandetanib and Bevacizumab in Treating Patients With Advanced Solid Tumors or Lymphoma | completed | Phase 1 | 18 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 16, 2012 | clinicaltrials |
| NCT00019019 | Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory Lymphomas | completed | Phase 1 | 70 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 15, 2012 | clinicaltrials |
| NCT00030108 | Ixabepilone in Treating Young Patients With Solid Tumors or Leukemia That Haven't Responded to Therapy | completed | Phase 1 | 30 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 15, 2012 | clinicaltrials |
| NCT00031941 | CC-5013 in Treating Patients With Cancer That Has Not Responded to Previous Therapy | completed | Phase 1 | — | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 15, 2012 | clinicaltrials |
| NCT00036959 | ABT-751 in Treating Young Patients With Refractory Solid Tumors | completed | Phase 1 | 90 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 15, 2012 | clinicaltrials |
| NCT00088868 | 17-Dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG) in Treating Patients With an Advanced Solid Tumor or Lymphoma | completed | Phase 1 | 40 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 15, 2012 | clinicaltrials |
| NCT00093444 | Heat Activated Liposomal Doxorubicin and Radiofrequency Ablation in Treating Patients With Primary or Metastatic Liver Tumors | completed | Phase 1 | 30 | National Institutes of Health Clinical Center (CC)NIH | 2 | Mar 15, 2012 | clinicaltrials |
| NCT00303940 | Talabostat Combined With Temozolomide or Carboplatin in Treating Young Patients With Relapsed or Refractory Brain Tumors or Other Solid Tumors | completed | Phase 1 | 26 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 15, 2012 | clinicaltrials |
| NCT00988195 | Study of Pegylated Human Recombinant Arginase for Liver Cancer | completed | Phase 1 | 15 | Bio-Cancer Treatment International LimitedINDUSTRY | 1 | Mar 14, 2012 | clinicaltrials |
| NCT01092091 | Study of Pegylated Human Recombinant Arginase for Liver Cancer (BCT-100-002)(BCT-100-002) | completed | Phase 1 / Phase 2 | 20 | Bio-Cancer Treatment International LimitedINDUSTRY | 1 | Mar 14, 2012 | clinicaltrials |
| NCT01348009 | Tesetaxel Plus Capecitabine and Cisplatin in Advanced Gastric Cancer | unknown | Phase 1 / Phase 2 | 63 | Genta IncorporatedINDUSTRY | 1 | Mar 13, 2012 | clinicaltrials |
| NCT00054977 | Safety of GM-CT-01 With and Without 5-Fluorouracil in Patients With Solid Tumors | completed | Phase 1 | 40 | Galectin Therapeutics Inc.INDUSTRY | 1 | Mar 12, 2012 | clinicaltrials |
| NCT00021047 | Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid Tumor | completed | Phase 1 / Phase 2 | — | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 8, 2012 | clinicaltrials |
| NCT00266097 | Oxaliplatin, Gemcitabine, Erlotinib, and Radiation Therapy in Treating Patients With Unresectable and/or Metastatic Pancreatic Cancer or Biliary Tract Cancer | completed | Phase 1 | 23 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Mar 7, 2012 | clinicaltrials |
| NCT01175447 | S-1 and Radiotherapy in Elderly Patients With Esophageal Cancer | completed | Phase 1 | 12 | Zhejiang Cancer HospitalOTHER | 1 | Mar 6, 2012 | clinicaltrials |
| NCT01175460 | S-1 Plus Nedaplatin With Concurrent Radiotherapy for Advanced Esophageal Cancer | completed | Phase 1 | 15 | Zhejiang Cancer HospitalOTHER | 1 | Mar 6, 2012 | clinicaltrials |
| NCT00429078 | Trial of 2nd Generation Anti-CEA Designer T Cells in Gastric Cancer | withdrawn | Phase 1 | 0 | Roger Williams Medical CenterOTHER | 0 | Mar 2, 2012 | clinicaltrials |
| NCT00821912 | TaxXel: Taxotere and Xeloda in Esophageal Cancer(TaxXel) | unknown | Phase 1 / Phase 2 | 93 | Karolinska University HospitalOTHER | 2 | Feb 28, 2012 | clinicaltrials |
| NCT00831493 | Vorinostat Plus Radiation Therapy in Pancreatic Cancer | terminated | Phase 1 / Phase 2 | 3 | M.D. Anderson Cancer CenterOTHER | 1 | Feb 28, 2012 | clinicaltrials |
| NCT01147991 | Vaccine Therapy in Treating Patients With Epstein-Barr Virus-Related Cancer | completed | Phase 1 | 16 | Cancer Research UKOTHER | 1 | Feb 28, 2012 | clinicaltrials |
| NCT01212887 | Treated Blood Cells, Cyclophosphamide, Fludarabine Phosphate, and Aldesleukin in Treating Patients With Cancer | terminated | Phase 1 | 14 | Cancer Research UKOTHER | 1 | Feb 28, 2012 | clinicaltrials |
| NCT00280176 | Bortezomib, Fluorouracil, and External-Beam Radiation Therapy in Treating Patients With Stage II, Stage III, or Stage IV Rectal Cancer | completed | Phase 1 | 11 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Feb 14, 2012 | clinicaltrials |
| NCT00777478 | Capiri-sutent Phase-1 in Advanced Colo-rectal Cancer(sutent-capiri) | unknown | Phase 1 | 32 | Radboud University Medical CenterOTHER | 1 | Feb 3, 2012 | clinicaltrials |
| NCT01131689 | Trial of S-1 in Combination With Sorafenib for Patients With Advanced Hepatocellular Carcinoma | completed | Phase 1 | 20 | Samsung Medical CenterOTHER | 1 | Feb 2, 2012 | clinicaltrials |
| NCT01031784 | Radioactive Holmium Microspheres for the Treatment of Liver Metastases(HEPAR) | completed | Phase 1 | 15 | UMC UtrechtOTHER | 1 | Jan 31, 2012 | clinicaltrials |
| NCT00062348 | Boronophenylalanine-Fructose Complex (BPA-F) and/or Sodium Borocaptate (BSH) Followed By Surgery in Treating Patients With Thyroid Cancer, Head and Neck Cancer, or Liver Metastases | completed | Phase 1 | 27 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 1 | Jan 20, 2012 | clinicaltrials |
| NCT00898287 | Safety and Efficacy Study of P276-00 in Combination With Gemcitabine in Patients With Advanced Pancreatic Cancer(SAVIOR) | completed | Phase 1 / Phase 2 | 23 | Piramal Enterprises LimitedINDUSTRY | 1 | Jan 20, 2012 | clinicaltrials |
| NCT00296062 | Dose Dense Therapy and Bevacizumab in Solid Tumors and Colorectal Cancer | terminated | Phase 1 | 12 | Case Comprehensive Cancer CenterOTHER | 1 | Jan 16, 2012 | clinicaltrials |
Data updated 22 days agoSource updated Jun 22, 2012source: clinicaltrials